Takaya Shiozaki

Takaya Shiozaki

Auto-generated profile, based on publicly available information

Takaya Shiozaki

Department of Gynecologic Oncology Hyogo Cancer Center Akashi Japan

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
HMHarunobu Matsumoto
Harunobu Matsumoto
MSMototsugu Shimokawa
Mototsugu Shimokawa
KNKaei Nasu
Kaei Nasu
ASAyumi Shikama
Ayumi Shikama
TSTakaya Shiozaki
Takaya Shiozaki
NTNorihiro Teramoto
Norihiro Teramoto
We conducted a retrospective, multi-institutional, collaborative study to accumulate cases of neuroendocrine carcinoma of the endometrium, to clarify its clinicopathologic features, treatment, prognosis and prognostic factors to collate findings to establish future individualized treatment regimens. To our knowledge, this is the largest case study and the first study to statistically analyze the prognosis of this disease. At medical institutions participating in the Kansai Clinical Oncology Group/Intergroup, cases diagnosed at a central pathologic review as neuroendocrine carcinoma of the endometrium between 1995 and 2014 were enrolled. We retrospectively analyzed the clinicopathologic features, treatment, prognosis and prognostic factors of this disease. A total of 65 cases were registered from 18 medical institutions in Japan. Of these, 42 (64.6%) cases were diagnosed as neuroendocrine carcinoma of the endometrium based on the central pathological review and thus included in the study. Advanced International Federation of Gynecology and Obstetrics stages (stage III and IV) and pure type small cell neuroendocrine carcinoma cases had a significantly worse prognosis. Upon multivariate analysis, only histologic subtypes and surgery were significant prognostic factors. Pure type cases had a significantly worse prognosis compared to mixed type cases and complete surgery cases had a significantly better prognosis compared to cases with no or incomplete surgery. Our findings suggest that complete surgery improves the prognosis of neuroendocrine carcinoma of the endometrium. Even among cases with advanced disease stages, if complete surgery is expected to be achieved, clinicians should consider curative surgery to improve the prognosis of neuroendocrine carcinoma of the endometrium.

17 May 2021 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
PDF file
TSTakashi Shibutani
Takashi Shibutani
SNShoji Nagao
Shoji Nagao
KSKazuhiro Suzuki
Kazuhiro Suzuki
KYKasumi Yamamoto
Kasumi Yamamoto
TJTomoatsu Jimi
Tomoatsu Jimi
SYSatoshi Yamaguchi
Satoshi Yamaguchi

1 September 2012 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
TSTakaya Shiozaki
Takaya Shiozaki
TTTsutomu Tabata
Tsutomu Tabata
TMTakashi Motohashi
Takashi Motohashi
Eiji KondoEiji Kondo
Eiji Kondo
KTKouji Tanida
Kouji Tanida
TITomoaki Ikeda
Tomoaki Ikeda